Pursuant to the provisions of Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are submitting herewith the following: 1. Unaudited Financial Results for the quarter ended 30th June, 2018; and 2. Limited Review Report for the quarter ended 30th June, 2018.

Pdf Link: Anuh Pharma Ltd. - Unaudited Financial Results & Imited Review Report For The Quarter Ended 30Th June, 2018

Source : BSE - www.bseindia.com